Global Hemp Group Announces Stephen D. Barnhill Jr. Has Been Appointed Interim President & CEO
Global Hemp Group Announces Stephen D. Barnhill Jr. Has Been Appointed Interim President & CEO
Vancouver, British Columbia--(Newsfile Corp. - March 20, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") announces that Stephen D. Barnhill Jr. has been appointed interim President & CEO effective immediately. Curt Huber, former President & CEO will remain as a Director of the Company and will oversee GHG's continuing industrial hemp related business segments.
溫哥華,不列顛哥倫比亞省-(Newsfile Corp.-2023年3月20日)-Global Hanp Group Inc.(CSE:GHG)(場外粉色:GBHPF)(法蘭克福證券交易所:GHG)(“GHG”或“公司”)宣佈:任命總裁為臨時首席執行官,即日起生效。前總裁首席執行官柯特·胡貝爾將繼續擔任公司董事的一員,並將負責GHG持續的工業大麻相關業務部門。
Mr. Barnhill is currently the Chief Operating Officer (COO) of Apollon Formularies, plc, a natural biologics drug discovery company publicly traded on the Aquis Exchange in London, UK. As Apollon's COO, he is responsible for all company operations in Jamaica, the Caribbean and North America. Stephen will be stepping down from that position immediately to become the Interim CEO of Global Hemp Group.
巴恩希爾先生目前是阿波隆配方公司的首席運營官(COO),該公司是一家在英國倫敦Aquis交易所上市的天然生物製劑藥物研發公司。作為阿波龍的首席運營官,他負責公司在牙買加、加勒比海和北美的所有業務。斯蒂芬將立即辭去這一職務,成為環球大麻集團的臨時首席執行官。
Stephen is the Co-Founder and President of Apollon Formularies, Inc. a US corporation established in 2014. He was instrumental in the international expansion of Apollon Formularies, Inc. to Jamaica in 2015, co-founding Apollon Formularies Jamaica, Ltd with headquarters in the Faculty of Medical Sciences at the University of the West Indies, Mona in Kingston. Apollon Formularies Jamaica, Ltd has a suite of vertical medical cannabis licenses from the Cannabis License Authority (CLA) including Cultivation Research and Development (allowing clinical trials), Processing, and Retail Therapeutic, an International Cancer and Chronic Pain Institute (ICCPI) in Kingston operating with a team of licensed medical doctors, Natural Psychedelic Therapeutics, Ltd to treat patients with psilocybin and an international medical tourism facility on the sea in Negril which treats international patients coming to Jamaica for treatment with Apollon's natural biologic products.
斯蒂芬是阿波龍配方公司的聯合創始人和總裁,這家美國公司成立於2014年。2015年,他為阿波龍配方公司向牙買加的國際擴張發揮了重要作用,與人共同創立了阿波龍配方公司牙買加有限公司,總部設在金斯敦莫納莫納西印度大學醫學院。阿波隆配方藥房牙買加有限公司擁有大麻許可證管理局(CLA)頒發的一套垂直醫用大麻許可證,包括種植研究和開發(允許臨床試驗)、加工和零售治療,位於金斯敦的國際癌症和慢性疼痛研究所(ICCPI)與一支有執照的醫生團隊自然致幻藥物治療有限公司合作治療裸蓋菇素患者,以及在內格裡爾的一個國際醫療旅遊設施,該設施治療來牙買加用阿波隆天然生物製品治療的國際患者。
Mr. Barnhill was also involved in the expansion of Apollon to Europe transitioning the company to Apollon Formularies, plc, a publicly traded company on the Aquis Exchange in London, UK and was appointed COO of Apollon Formularies, plc. Stephen was also Founder and CEO of CBev Ventures, Inc., a medical cannabis beverage company offering the High Spirits brand of drinks.
巴恩希爾先生還參與了Apollon向歐洲的擴張,將公司過渡到Apollon Forulary,plc,這是一家在英國倫敦Aquis交易所上市的公司,並被任命為Apollon Formary,plc的首席運營官。斯蒂芬也是CBev Ventures,Inc.的創始人兼首席執行官,CBev Ventures,Inc.是一家醫用大麻飲料公司,提供High Spirits品牌的飲料。
In addition, the Company would also like to announce that the terms of the binding LOI executed on January 9, 2023 with Apollon Formularies plc (see the Company's news release of January 11, 2023 for further details) has been amended. The Parties have agreed to extend the due date of the final payment of US$150,000 relating to the Exclusive North American Licenses granted by Apollon, to on or before March 31, 2023. Further, in order to complete the due diligence process, the Parties have extended the due diligence period and GHG's option to acquire the entirety of Apollon's assets to April 28, 2023, unless waived by mutual agreement of the Parties prior to that date.
此外,本公司還宣佈,於2023年1月9日與Apollon Formary plc簽署的具有約束力的意向書的條款已被修訂(有關進一步細節,請參閱本公司2023年1月11日的新聞稿)。雙方同意將與Apollon授予的北美獨家許可證有關的150,000美元最終付款的到期日延長至2023年3月31日或之前。此外,為了完成盡職調查程式,雙方已將盡職調查期和GHG收購Apollon全部資產的選擇權延長至2023年4月28日,除非在該日期之前雙方同意放棄。
Subscribe to the GHG YouTube Channel:
訂閱GHG YouTube頻道:
Like us on Facebook:
就像我們在臉譜網上:
Follow us on Instagram:
在Instagram上關注我們:
Follow us on Twitter:
關注我們的推特:
Connect with us on LinkedIn:
在LinkedIn上與我們聯繫:
About Global Hemp Group Inc.
環球大麻集團公司簡介
Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) is focused on executing a multi-phased strategy to become a leader in the industrial hemp industry. To further support and innovate, GHG has established a R&D Division to actively pursue the development of Intellectual Property that can be patented for implementation at its projects and beyond. The Division is led by Prof. Víctor M. Castaño, Ph.D. whose career has focused in the areas of applied science and technology. The R&D team will initially focus on development of Environmentally Friendly Construction Materials, Nanofertilizers and Enhanced Extraction from Hemp.
全球大麻集團公司(CSE:GHG)(場外交易市場代碼:GBHPF)(FSE:GHG)專注於執行多階段戰略,以成為工業大麻行業的領導者。為了進一步支持和創新,GHG成立了一個研發部門,積極從事知識產權的開發,這些知識產權可以在其專案和其他專案中獲得專利實施。該司由Víctor M.Castaño教授領導,他的職業生涯專注於應用科學和技術領域。研發團隊最初將專注於開發環保建築材料、納米肥料和從大麻中強化提取。
For Further Information Contact Global Hemp Group
欲瞭解更多資訊,請聯繫環球大麻集團
Investor Relations
投資者關係
Tel: 778-726-2900
電話:778-726-2900
info@globalhempgroup.com
郵箱:info@lobalhempgroup.com
Cautionary Note Regarding Forward Looking Statements
有關前瞻性陳述的注意事項
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to, the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk, and the legality of cannabis and hemp. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of Page 2 of 2 preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Except as required by law, Global Hemp Group Inc. disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
本新聞稿中陳述的某些資訊可能包含前瞻性陳述,這些陳述涉及大量已知和未知的風險和不確定性。這些前瞻性聲明會受到許多風險和不確定性的影響,其中某些風險和不確定性是Global hemp Group Inc.無法控制的,包括但不限於總體經濟狀況、行業狀況、大宗商品價格的波動、匯率波動、對監管部門批准的依賴、未來融資和勘探風險的獲得以及大麻和大麻的合法性。請讀者注意,編制此類資訊時使用的假設雖然在編制第2頁時被認為是合理的,但可能被證明是不準確的,因此不應過度依賴前瞻性陳述。除非法律另有要求,否則Global hemp Group Inc.無意更新或修改任何前瞻性陳述,以反映實際結果,無論是由於新資訊、未來事件、假設的變化、影響此類前瞻性陳述的因素的變化或其他原因。
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
CSE未對本新聞稿的充分性或準確性進行審查,也不承擔任何責任。
To view the source version of this press release, please visit
要查看本新聞稿的源版本,請訪問